News | December 20, 2012

Mammomat Inspiration Prime Edition features new software intended to correct scattered radiation


December 20, 2012 — At the 98th annual meeting of the Radiological Society of North America (RSNA) Siemens Healthcare displayed the Mammomat Inspiration Prime Edition, designed to be the first mammography system that lowers patient dose up to 30 percent without compromising image quality.

The Mammomat Inspiration Prime Edition is intended to lower dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction. This new algorithm is intended to identify scatter-causing structures and calculates a corrected image, enabling complete use of primary radiation so physicians can achieve high-quality images using less dose. The development of products like the digital full-field Mammomat Inspiration is a goal of Siemens Healthcare’s global Agenda 2013 initiative.

In digital X-ray breast imaging, radiation passes through the examined breast to a detector. Primary radiation supplies the information needed to produce the X-ray image, while scattered radiation is absorbed by special grids positioned between the breast and the detector. Unfortunately, these scatter grids also absorb part of the all-important primary radiation, forcing physicians to use a higher dose to obtain images of desired quality.

Siemens’ new reconstruction algorithm for the Mammomat Inspiration system – known as Prime (Progressive Reconstruction, Intelligently Minimizing Exposure) – is intended to eliminate the need for the conventional scatter radiation grid. The Prime algorithm is designed to correct the scattered radiation by identifying scatter-causing structures and recalculating the image. The primary radiation that radiologists rely upon remains intact and a grid is no longer necessary; therefore lower doses are sufficient to produce high-quality images. The grid-free imaging technology of the Mammomat Inspiration Prime Edition is intended to reduce radiation dose up to 30 percent compared to its predecessor model, depending on the thickness of the patient’s breast tissue.

The system is based on the modular Mammomat Inspiration platform for screening, diagnostics and biopsy used by hospitals and physicians’ offices since 2007. Facilities have the option of purchasing the basic equipment, upgrading to biopsy or tomosynthesis features later as the need arises.

The Mammomat Inspiration Prime Edition is pending 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is not yet commercially available in the United States.

For more information: www.siemens.com/healthcare


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now